Diabetes pill trial aims to shrink Kids' fatty livers
Disease control
Not yet recruiting
This study is testing if a diabetes medication called empagliflozin can safely reduce fat in the liver of teenagers with obesity-related fatty liver disease (NAFLD). Forty adolescents will take the pill or a placebo daily for six months while also receiving lifestyle counseling. …
Phase: PHASE2 • Sponsor: Justin Ryder • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC